Assess your drug launch readiness across 8 critical dimensions with 24 targeted questions. Get your readiness score, gap analysis, and timeline recommendations in under 10 minutes.
Get a detailed launch planning template with timelines, RACI charts, and milestone trackers based on your readiness assessment.
25+ KPIs tracked across all marketing channels with benchmarks.
Get Template →Compare territory performance against industry benchmarks.
Benchmark Now →Score your omnichannel readiness across 5 key dimensions.
Take Assessment →A pharmaceutical brand launch is one of the most high-stakes events in the life sciences industry. Research shows that brands achieving peak market share within the first 12 months outperform late bloomers for the entirety of their lifecycle. Yet nearly 50% of drug launches underperform expectations, often due to gaps in cross-functional readiness rather than product efficacy. A structured launch readiness assessment helps commercial teams identify and close gaps before they impact in-market performance.
Successful pharma launches require alignment across eight critical dimensions. Market research provides the foundation with disease landscape analysis, patient and HCP segmentation, and competitive intelligence. Regulatory and MLR readiness ensures your promotional materials are approved and your claims strategy is defensible. Sales force readiness covers territory alignment, training certification, and CRM deployment.
Marketing materials and content must include a complete message hierarchy, promotional material suite, and digital content. KOL and medical strategy ensures opinion leaders are engaged through advisory boards and speaker programs. Market access and pricing addresses formulary strategy, value dossiers, and patient access programs. Digital and omnichannel readiness ensures coordinated engagement across all channels. Finally, metrics and analytics provides the KPI framework and tracking infrastructure to measure and optimize performance post-launch.
The most common launch failures stem from underestimating the time required for MLR review cycles, inadequate field force training, delayed payer submissions, and lack of omnichannel coordination. Teams that begin their readiness assessment 18 to 24 months before anticipated approval consistently outperform those that start later. Early identification of gaps allows for course correction while there is still time to execute.
Another frequent mistake is treating the launch as a single event rather than a sustained campaign. The most successful brands plan for a 12-month launch window with phased activations, ongoing field coaching, and continuous optimization based on real-world data. This checklist helps you assess readiness across all dimensions so you can prioritize resources and build a launch plan that drives peak performance.
Complete the 24-question checklist across all 8 dimensions to get your overall readiness score. Each question is scored on a 1 to 4 scale, where 1 represents not started and 4 represents fully prepared. Your results include dimension-by-dimension scores, identification of your top gap areas with specific recommendations, and a suggested pre-launch timeline based on your current readiness level. For the most accurate assessment, involve your cross-functional launch team including commercial, medical, regulatory, and market access leads.